our approach
Platform Technology
We create products from qualified ‘single birth’ placental donors.
Utilizing cryopreservation and freeze-drying technologies to concentrate and focus the biological active components:
- Exosomes and their cargo
- Growth factors
- Peptides
- Cytokines
- miRNA
- Mesenchymal stem cells
We create products across 3 categories:
Membrane patches
Injectable regenerative therapeutics
Topical cosmetics
Technology innovation
BioXtek’s manufacturing platform, expansive IP development programs, and regulatory pathways create:
Competitive advantage
Our omni-channel approach provides competitive advantage in different markets; each with significant growth potential.
Revenue trajectory
Already revenue-generating, BioXtek’s commercial plans target both near-term and larger,longer-term market opportunities.
